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Background: Little is known about the cause and psychopathology of delirious mania, a type of disorder where
delirium and mania occur at the same time. This condition still has no formal diagnostic classification. To provide
more information about this potentially life-threatening condition, we studied five patients with delirious mania.
Methods: We describe the cases of five patients with delirious mania admitted to an acute inpatient psychiatric
unit between January 2005 and January 2007, and discuss the cases in the context of a selective review of the
clinical literature describing the clinical features and treatment of delirious mania.
Results: Two patients had two episodes of delirious mania. Delirium usually resolved faster than mania though not
always the case. Delirious mania remitted within seven sessions of the electroconvulsive therapy (ECT).
Conclusions: Delirious mania is a potentially life-threatening but under-recognized neuropsychiatric syndrome.
Delirious mania that is ineffectively treated may induce a new-onset manic episode or worsen an ongoing manic
episode, and the patient will need prolonged hospitalization. Delirious mania also has a close relationship with
catatonia. Early recognition and aggressive treatment, especially with electroconvulsive therapy, can significantly
reduce morbidity and mortality.
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Concurrence of delirium and mania is unusual. While
delirious mania is not described in the Diagnostic and
Statistical Manual of Mental Disorders, fourth edition
(DSM-IV), it does exist through the evidence of clinical
reports. The syndrome was first described by Calmiel in
1832. In 1849, Luther Bell, who is credited with providing
the first comprehensive description of the syndrome,
reported 40 patients with the condition out of 1700
admissions to McLean Hospital [1]. Three-quarters of
these patients died. In 1921, Kraepelin categorized mania
into 3 types: acute, delusional, and delirious [2,3]. To bet-
ter describe the range of severity, Klerman [4] described
the spectrum of mania in 5 stages: normal, neurotic, hypo-
manic, manic, and delirious. However, the description of
delirious mania provided in Klerman’s classification was
very similar to the delusional type defined earlier by* Correspondence: 400786@cch.org.tw
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reproduction in any medium, provided the orKraepelin, and it would be coded as bipolar I disorder,
manic episode with psychotic feature in the DSM-IV. Here
delirious mania is defined much more closely to the ex-
tremely severe group in the final stage, stage III mania
described by Carlson and Goodwin [5].
There is no clear consensus on the clinical characteris-
tics associated with delirious mania or guidelines for
treatment. Recognition of this syndrome is further com-
plicated by the fact that many cases of delirious psychi-
atric patients are precipitated by medical or neurological
conditions or use of psychoactive substances.
Other studies have shown a high incidence of disorien-
tation, confusion, or delirium among manic inpatients,
and have noted that these patients tend to be hospita-
lized longer than are manic patients without these add-
itional symptoms [4-6]. These patients presented specific
features other than a combination of typical mania and
delirium. Karmacharya et al [1] mentioned some dis-
tinctive symptoms of delirious mania and described
some severe forms of familiar manic/psychotic symp-
toms, which could provide clues about delirious mania.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Incidence of specific features observed
Specific features Incidence
Having 2 or more episodes of
delirious mania
2/5 (patient 1 and 2)
Delirium resolving faster than mania 4/5 (exception: 2nd
episode of patient 1)
Fulfilled Fink’s criteria of catatonia 2/5 (patient 2* and 3)
Fulfilled criteria of catatonia in DSM-IV 3/5 (patient 1*, 2* and 3)
Treatment of pharmacotherapy and ECT 2/5 (patient 3 and 4)
Delirious mania remitted within 7
sessions of ECT
2/2
Treatment: only pharmacotherapy 3/5 (patient 1, 2 and 5)
Delirious mania lasting over 2 months 1/3 (patient 1 had 2 episodes)
* = clinical symptoms on the borderline for specific symptoms of catatonia
because of limited frequency and severity.
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diagnosis in the current nosology because many terms
have been used over the years to describe patients pre-
senting with mania, including excitement, delirium, and
altered consciousness with/without catatonic symptoms.
Other terms included lethal catatonia, malignant catato-
nia, delirious mania, and Bell’s mania [1,7]. Some
authors have pointed to the high incidence of catatonic
symptoms occurring in patients with delirious mania
and also to the fact that both catatonia and delirious
mania respond to electroconvulsive therapy (ECT)
[8-10]. Taylor and Fink [10] provided a classification of
catatonia, and suggested that it be reclassified as an indi-
vidual abnormal behavior akin to delirium and dementia,
while delirious mania was posited in the same subtype as
delirious catatonia (delirious mania, excited catatonia)
[10-12]. Karmacharya et al [1] did not find a large num-
ber of catatonic signs and symptoms in their study, while
Detweiler et al [11] supported Fink’s proposal.
In an attempt to better describe the course of delirious
mania and to provide a clearer picture of this illness, we
present a series of 5 patients diagnosed with delirious
mania. Our goal was to provide additional information
about delirious mania and to illustrate the features of
this condition and to highlight several challenges clini-
cians and researchers face in recognizing and treating
this syndrome.
Methods
We present the cases of five patients from our clinical
practice at our ward. The criteria we used to select these
cases include: (a) concurrent manic and delirious symp-
toms during hospitalization, and (b) medical workup
failed to uncover an organic cause for either mania or
delirium. Informed consent was obtained from the five
patients for publication of this report.
Results
Some specific features observed in these five cases were
summarized in Table 1.
Case reports
Patient 1
A 53-year-old male began acting oddly about 1 month
prior to being admitted to the hospital. His family
reported that his speech was pressured, and that he had
begun wandering about without seeming to know where
he was going. He also had outbursts of anger and exhib-
ited destructive behavior as well. After burning newspa-
pers at home and threatening his family, he was sent to
the emergency room and was then admitted to the psy-
chiatric ward.
His medical history indicated that he had been diag-
nosed with bipolar I disorder at age 22 and had beenhospitalized several times for treatment of manic epi-
sodes. He had been followed up at our clinic since he
was 37 years of age. At age 49, he presented manic
symptoms, including hyperactivity, incomprehensible
speech, talking to himself, uncontrollable emotional out-
bursts, and destructive acts. After admission, he contin-
ued to have disorganized speech patterns, distractibility,
and agitation. He exhibited grandiosity, had auditory and
visual hallucinations, and showed occasional catatonia-
like signs of excessive motor movement, purposeless
walking around with mundane postures, and inexplic-
ably squatting at corners. Because of his severe and wor-
sening disorientation and marked inattention, a
diagnosis of delirium and bipolar mania was entertained.
Results of a detailed physical examination were unre-
markable. No fever was detected and his blood pressure
was normal. Vitamin B12 and folic acid levels were
within normal ranges, and his electroencephalograms
were normal. As a result, the diagnosis was changed to
delirious mania. The physician proposed ECT, but the
patient’s family refused it.
The patient was placed on a regimen of haloperidol
decanoate, 50 mg/wk; valproate, 1500 mg/day (level:
53.89 mEq/L to 95.35 mEq/L); lithium carbonate,
600 mg/day (level: 0.35-0.74 mEq/L); trihexyphenidyl,
10 mg, and chlorprothexine, 100 mg/day. In addition,
flunitrazepam, 2-4 mg/day, was given for severe insomnia
throughout the patient’s hospitalization, with episodic
augmentation of dormicum, 15 mg/day, and trazodone,
100 mg/day. Clonazepam, 4-10 mg/day, was prescribed
for agitation. We considered decreasing the dosage of the
antipsychotics, to avoid neurotoxicity, but this became
impossible because the patient became ever more agi-
tated and had to be restrained for longer periods.
About 15 days after he was admitted, we noticed he had
general weakness, and replaced clonazepam with loraze-
pam, 1-7 mg/day, according to the severity of agitation.
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intramuscularly nine times for controlling his aggressive
agitation from day 2 to day 33. After day 33, chlorpromaz-
ine, 25-50 mg, was injected intramuscularly three times
for aggressive agitation because lorazepam had produced
only a limited effect. Trihexyphenidyl, 10 mg/day, was
used before admission and continued because of concern
about the increased risk of the extrapyramidal syndrome
(EPS). The patient had no obvious symptoms of EPS. Con-
stipation was observed episodically, so 24 mg/day of sen-
noside was given initially and then replaced by dulcolax,
10 mg/day. On the 71st day after admission, the patient
was discharged without full remission. This occurred
against his clinicians’ advice, but his family thought he had
been hospitalized too long and they felt he seemed less
agitated. His discharge medications remained the same,
with the exception of the addition of oral haloperidol,
15 mg/day. His symptoms remitted about 2 weeks after
discharge. His family claimed he took his medication as
ordered after discharge.
At the latest admission, the patient’s manic behavior
warranted close monitoring and frequent seclusion. His
speech was rambling and pressured. His mood was ele-
vated, and he was distracted, hostile. He impulsively and
inappropriately touched other patients but not in a sex-
ual manner and had urinary and fecal incontinence. He
occasionally walked around aimlessly and once more
squatted at corners purposelessly, which seemed to be
catatonia-like signs. His delirium was worsening, with
disorientation as to time and place. All this made his
medical care very difficult.
The results of laboratory studies, including thyroid
function tests, were normal. Physical examination
showed no signs of inflammation or infection. The
patient’s vital signs were normal. The clinical impression
was delirious mania. The family once more refused ECT.
In an attempt to control his behavior, valproate (level:
66.44 mEq/L to 105.29 mEq/L), and lithium carbonate
(level: 0.81 mEq/L to 1.16 mEq/L), were used concur-
rently with augmentation of his antipsychotic medica-
tion. The dose was titrated to maintain the valproate
level at around 100 mEq/L and lithium at 1 mEq/L for
expected maximal therapeutic effect. Trazodone,
100 mg/day, and lorazepam, 4 mg/day, were adminis-
tered for their hypnotic effect. In addition, the antipsy-
chotics were immediately started after the patient was
readmitted. The initial agent selected was olanzapine
(15 mg for 5 days), and this was then changed to quetia-
pine (50 mg for 3 days) and zotepine (100 mg to 200 mg
for 1 month) in order to make him slightly sleepy. The
manic symptoms gradually improved: Young Mania
Rating Scale (YMRS) score declined from 42 (on day 9),
peaked at 46 (day 16), then fell to 20 (day 30), and
remained between 15-24. The patient’s YMRS score was15 at discharge, but his delirium did not resolve. He
seemed sleepy most of the time, but was episodically agi-
tated and uncooperative with his treatment. His inatten-
tion and agitation made oral intake difficult and led to
frequent choking. Nasopharyngeal tube feeding was
sometimes needed. The hypoactivity with his sleepy state
and slightly rigid limbs made catatonia and EPS difficult
to rule out. But he had neither other catatonic symp-
toms such as echolalia nor hypertension and fever. Con-
cern about EPS, catatonia, and anticholinergic-induced
delirium led us to change the zotepine to quetiapine
(400 mg to 500 mg for the remaining month) and to re-
duce the trihexyphenidyl dosage, from the initial 10 mg/
day to 2 mg/day for the remainder of his hospitalization.
At the same time, lorazepam was injected intramuscu-
larly for agitation control, at a dosage of 1 mg/day (given
one time) and 2 mg/day, given seven times from day 2
to day 77.
For financial reasons, the family arranged to have the
patient transferred to another hospital. At discharge, he
still had occasional delirium but he was much more co-
operative with staff members. Two months later, he
returned to our clinic, and was in near-remission but he
had no clear memory about his treatment at the other
hospital and thus couldn’t provide any information
about the regimen at the other hospital.
Patient 2
A 58-year-old male had a history of bipolar I disorder
and was being treated at a local clinic. His treatment
regimen included lithium carbonate, 1500 mg/day,
carbamazepine, 600 mg/day; haloperidol, 2 mg to 5 mg/
day (titrated as needed); and trihexyphenidyl, 5 mg/day.
His performance at work had deteriorated for several
months prior to admission. Six weeks prior to admis-
sion, he began to show emotional lability, talking to him-
self, laughing hysterically, and exhibiting unusual
behavior, such as remaining naked for an inappropriately
long time after bathing. He presented at an outpatient
clinic, displaying mania and was in a generally disorga-
nized condition. Both delirium and dementia were sus-
pected. His medication was adjusted at the clinic after
symptoms developed, so this ruled out drug-induced
delirium. After receiving 150 mg of zuclopenthixol, he
showed general weakness and disorientation at night.
Four days prior to admission, he had been treated with
risperidone, 4 mg, and carbamazepine, 200 mg, because
it was felt that the EPS might have been induced by use
of traditional antipsychotics. He was finally admitted to
the hospital because of irritability, loose associations,
and talking to himself.
The bipolar disorder could be traced back to age 29,
when his manic behavior led to hospitalization for
1 month. During that episode, disorientation was also
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abused substances in the past.
On admission, the patient presented with mixed symp-
toms of delirium and mania. He was inattentive, disor-
ientated as to time, place, and person, and unable to find
his bed. He was awake all night, busy without clear goals,
spoke incoherently and had decreased appetite and in-
take. He took boxing stances and pumped his thigh at
times without reason, showing catatonia-like symptoms.
Electroencephalographic (EEG) results showed poor
alpha waves and mild cortical dysfunction. The neurolo-
gist thought this was a normal pattern frequently seen in
aging patients and indicated no specific illness. A com-
puted tomography (CT) scan indicated an “aging brain,”
with mild ventricular dilatation and mild widening of the
cortical sulci. Vitamin B12 and folic acid levels were
within normal ranges. Thyroid-stimulating hormone
(TSH) levels were also within normal limits, while free
thyroxine (T4) levels were slightly lower than normal
(0.69 ng/dL; normal range: 0.7-1.48 ng/dL). Delirious
mania was considered the cause for his delirium because
there was no acute precipitating physical illness. His fam-
ily refused the suggestion of ECT because they were not
familiar with it.
After this, the patient was treated with risperidone,
4 mg/day, and valproate, 500 mg to 1000 mg/day (level:
98.28 μg/mL). On about the sixth day of treatment, he be-
came oriented. The manic picture became much clearer
in the following days. On the 11th day, lithium, 300 mg to
900 mg/day, was titrated up because the patient had gone
several consecutive nights without sleep. On the 15th day,
quetiapine, 600 mg/day, replaced risperidone (4 mg/day)
for his insomnia. When daytime drowsiness occurred for
2 consecutive days, quetiapine was then replaced by olan-
zapine, 20 mg/day. For insomnia, estazolam, 4 mg, or flu-
nitrazepam, 2 mg, was used, depending on the severity of
the insomnia. But lorazepam, 2 mg/day, was given 3 times,
and zolpidem, 10 mg/day, or zopiclone, 15 mg/day, was
administered 17 times more episodically as the patient’s
insomnia worsened. The patient was discharged in partial
remission about 1 month later because the family chose to
care for him at home. The regimen at discharge was olan-
zapine, 20 mg/day; flunitrazepam, 2 mg/day; trihexypheni-
dyl, 6 mg/day (successfully treating the drug-induced EPS
and rigidity of limbs); magnesium oxide, 750 mg/day; and
lithium, 900 mg/day. The patient’s mood stabilized over
the next 2 months, and there was no recurrence of
delirium.
Patient 3
A 67-year-old male began an active campaign for local
elective office 1 month before being admitted to the hos-
pital’s psychiatric unit. After 2 weeks of campaigning, he
developed pressured speech and irritability, remainedoutside all day, and increased his normal intake of food
and fluids. A week later he had insomnia, confusion, an
unsteady gait, and frequent falls. On the day of admis-
sion, he was found kneeling in the street.
The patient had a history of peptic ulcer, pyloric sten-
osis, gallstones, and adhesive ileus that had been treated
by vagotomy, gastrectomy, cholecystectomy, and entero-
lysis. His first episode of depression occurred at age 58.
He was admitted twice for manic episodes, and the last
psychiatric hospitalization was 5 years prior to this
admission. His regular regimen included lithium carbon-
ate, 600 mg/day; trihexyphenidyl, 2 mg/day; clonazepam,
3 mg/day; and diazepam, 4 mg/day. A month before
admission, bupropion, 75 mg/day, and olanzapine,
10 mg/day, had been added to help stabilize his mood.
After admission, he had the typical picture of mania,
with euphoria, pressured speech, and over-involvement
with other individuals, and he created frequent interper-
sonal conflicts on the ward. Bupropion was discontinued
immediately. Because of tongue dyskinesia, the olanza-
pine was changed to quetiapine, 400 mg/day. Three
weeks later, delirium appeared. He became disoriented.
He was frightened by visual hallucinations, and angry at
the staff, whom he believed had transported him to “the
train station.” His lithium level was 0.41 mEq/L to
1.18 mEq/L while he was hospitalized. His white blood
cell count (WBC) was elevated to 18100/uL, Segment
83%, but there was no fever or evidence of infection. He
had an inguinal hernia, which was believed to be the
source of his leukocytosis, but the hernia could be
moved in place by the surgeon without any sign of infec-
tion. Two weeks later, the WBC count decreased to
6900/uL without antibiotics. Thus, infection was ruled
out as a possible cause for delirium. The results of elec-
trolytes and renal and hepatic function tests were nor-
mal. Results of CT scans were unremarkable. On the
12th day, an abnormal EEG was recorded, with mild-to-
moderate cortical dysfunction without epileptic findings.
The patient’s delirium persisted, along with persecutory
delusions, fear of eating, and with agitation, kicking, and
shouting. Delirious mania was suspected.
Bilateral ECT was begun on the 29th hospital day, and
performed 3 times a week. After the fourth session, the
patient’s orientation improved, but there were also signs
of depression. Before the patient presented with depressed
mood, he accepted 2-mg injections of lorazepam for agita-
tion. The injections were given 14 times from day 4 to day
34, and 2 doses were given before delirium occurred. After
the fifth session of ECT, his depression worsened. He tried
to leap from his bed in a suicide attempt after the sixth
session of ECT. He was totally oriented after the seventh
session, but his depression persisted. Paroxetine, 10 mg/
day, was started after the 12th ECT session, and lithium,
600 mg/day, was resumed after the 16th session. The
Lee et al. BMC Psychiatry 2012, 12:65 Page 5 of 9
http://www.biomedcentral.com/1471-244X/12/65patient’s depression improved after 17 sessions of ECT,
and resolved completely a month later. The discharge
regimen included: alprazolam, 1.5 mg/day; paroxetine,
10 mg/day; lithium, 600 mg; zopiclone, 15 mg/day; and lo-
peramide, 2 mg/day. Loperamide was added to the regi-
men because the patient had diarrhea when he ate watery
foods without his dentures.
Patient 4
A 50-year-old female had a 15-year history of bipolar dis-
order, which had resulted in four previous hospitalizations
for manic episodes. She was admitted to the nearby men-
tal health institute after 1 week of recurrent mania. During
that hospitalization, clinicians noted a change in her level
of consciousness. She developed aspiration pneumonia
with respiratory failure, and an endotracheal tube was
inserted. The patient was uncooperative and removed the
endotracheal tube. She was transferred to our medical de-
partment and seen in consultation by a psychiatrist.
Because of obvious manic symptoms of euphoria with
auditory hallucinations, incoherent speech, disorganized
behavior, and impulsively touching others’ faces, she was
transferred to the psychiatric ward after 5 days of med-
ical stabilization.
Her medication was changed from aripiprazole, 10 mg
to 15 mg/day (titrated up to control manic symptoms), to
quetiapine, 600 mg/day (replacing aripiprazole for insom-
nia); clonazepam, 3 mg/day; lithium, 600 mg/day (level:
0.2 to 0.47 mg); and lorazepam, 4 mg at bedtime. In
addition, lorazepam, 2 mg/day, was intramuscularly
injected on days 7 and 9 to control agitation. After this,
the patient was calm for hours. In addition to her manic
symptoms, she had prominent catatonic symptoms. She
alternated between excitement and mutism. She also dis-
played episodic absent-mindedness, with a staring expres-
sion, echolalia, and echopraxia. Because of her refusal to
eat or drink and frequent aggressiveness, she required
nearly constant restraint of her hands and had to be fed
via nasogastric tube. These catatonic symptoms pro-
gressed while delirious symptoms appeared as disorienta-
tion to time and place with chaotic consciousness 3 weeks
after the onset of mania. Fever subsided before delirium
appeared and the WBC count decreased from 13600 to
7100. A diagnosis of catatonia and delirious mania was
made, and bilateral ECT was begun on the 10th day of de-
lirium. The delirium subsided after the first session of
ECT and totally resolved after the second session, although
mania and psychosis remitted after the sixth session.
Patient 5
A 59-year-old male was admitted to the hospital with ele-
vated mood, irritability, irrelevant speech, hyperactivity,
poor sleep, odd feelings he described as an “earthquake,”
and auditory hallucinations.He had a history of bipolar I disorder beginning at age
32. He borrowed money irrationally with unclear plans
for its use, wandered around outside; slept poorly; and
ate sugar canes at another person’s fruit farm without
permission. His unusual symptoms occurred episodic-
ally, usually lasted about 10 days, and resulted in several
hospitalizations. At age 52, he underwent a frontoparie-
tal craniostomy because of an intracranial hemorrhage
after a traffic accident. Severe recent memory impair-
ment was observed after that accident. At age 54, he had
a single transient ischemic attack with left upper limb
weakness, but totally recovered. During outpatient psy-
chiatric follow-up, he once overdosed in an apparent
suicide attempt during a depressive episode. Because of
weight gain and depression, his dosage of risperidone,
3 mg/day, was discontinued 10 months prior to admis-
sion. Aripiprazole, 20 mg/day, and paroxetine, 10 mg/
day, were added to his treatment regimen, along with
extended-release valproate, in a dosage of 500 ~ 750 mg/
day, according to clinical response. However, drug com-
pliance was poor throughout the course of bipolar dis-
ease in his life. The paroxetine was discontinued at a
clinic visit 15 days before the patient was admitted after
he had experienced 2 days of insomnia, irritability and
grandiose thoughts.
When he was first admitted, aripiprazole, 20 mg/day,
was changed to immediate-release quetiapine, 400 mg/
day, to control insomnia while he was hospitalized. In
addition, lorazepam, 4 mg, was administered for insom-
nia. Three days after admission, delirium occurred. He
became disoriented about time and place. Inattention
and irrelevant speech were apparent, but his orientation
occasionally improved. A CT scan showed right tempor-
oparietal region postcraniotomy and generalized brain
volume loss with dilatation of sylvian fissures, cerebral
sulci, and ventricles, consistent with damage following a
past cerebrovascular accident (CVA). Results from bio-
chemistry and hematologic examination were unremark-
able. The patient’s symptoms improved without full
remission. Against medical advice, his family insisted
that he be discharged on the 10th hospital day. A week
later, he was fully oriented but it took an additional
month for his mood to return to baseline levels.
Discussion
Delirious mania in bipolar disorder
Because symptoms of delirious mania could be induced
by other medical illnesses, the cases selected in this art-
icle were patients in whom the bipolar disorder (BD)
was the primary cause of delirious mania.
Patient 1 was already ill and had not received medica-
tion when he was admitted to the hospital. Neuroleptic
malignant syndrome could be ruled out from his two
episodes because he had neither autonomic dysfunction
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mania was the most likely diagnosis for his delirious
state. Within 4 years he had recurrent delirious mania.
These two episodes produced very similar symptoms.
Patient 2 also presented with mania with delirium,
although there was a 30-year interval between the two
episodes. Other cases of recurrent delirious mania have
been reported [8,13]. These cases supported the theory
that BD patients have a high risk of delirium because de-
lirium could recur within the same patients.
Patients 3 and 4 had medical illnesses other than BD
at admission. In such cases, it is difficult to make a dif-
ferential diagnosis of the cause of delirium. The mild in-
guinal hernia in patient 3 and the resolution of
pneumonia in patient 4 may have made them vulnerable
to delirium [14]. However, these illnesses had been trea-
ted appropriately and presented no worsening signs that
would have required more aggressive management.
These patients’ obvious manic symptoms made delirious
mania the most likely diagnosis. In patient 4, prominent
catatonia was seen, and this was recognized as an im-
portant sign of delirious mania by Fink and Taylor [12].
Although patient 5 had a history of two episodes of
stroke and a craniostomy, the absence of a new brain le-
sion on CT scans ruled out the possibility of post-stroke
delirium. Patient 5 had poor drug compliance and he
took a below-normal dose of medication. Thus, in his
case delirious mania was unlikely to be caused by
medication.
In the usual clinical practice, BD patients with other
medical co-morbidities are not rare, like our patient 3, 4,
and 5. Delirious mania can be easily misdiagnosed in
some BD patients if they have chronic medical illness
and present with acute-onset excited delirium, which
could be difficult to differentiate from delirious mania.
The poor drug adherence of bipolar patients would make
even psychiatrists consider delirious mania as the very,
very last possibility. It explained that there is a high inci-
dence of delirium among BD patients (35.5%), but there
was little in the literature relating to delirious mania [20].
Delirious mania: A severe form of mania or another
syndrome?
For more than 200 years, the acute onset of agitated
dreamy or delirious states have perplexed clinicians.
Called “onirisme” in the French literature, some authors
still term this dreamy state oneirophrenia. The term
“delirious mania” is used to describe manic patients who
have delirious symptoms that occur and remit without
other evident medical reasons [1,2,8,10,13,15-17]. Ini-
tially Kraepelin, and then Carlson and Goodwin [5] and
Klerman [4] defined delirious mania as the most severe
type of mania. In their concept, delirious mania is part
of the spectrum of manic symptoms. Thus, its appearancewas only a level of severity but not a different etiology. In
1980, Bond reported three cases of delirious mania, add-
ing a more detailed clinical description of the disorder
[13]. He noted that delirium and mania presented acutely
and responded to the traditional treatment for bipolar
mania. The definition of delirious mania still was limited
to BD; however, many reports in the literature revealed
similar symptoms in medically ill patients without a his-
tory of BD [18,19]. Taylor and Fink attributed delirious
mania to a form of catatonia because of its good response
to ECT and the high frequency of catatonic signs reported
with it [8,10]. Thus, “delirious mania” has had a confusing
history and meaning because like catatonia it was treat-
able with ECT, but it was coined from delirium and
mania.
When only delirium subsided from delirious mania, we
supposed that delirious mania was gone while mania
remained. In patients 2, 4, and 5, delirious mania
responded quickly to effective treatment. This pattern has
been found in many case reports, no matter whether the
treatment is ECT or just pharmacotherapy [8,13,15-17]. It
took 2 more months for mania to remit in patient 2 after
his delirium disappeared. But on the second admission of
patient 1, when mania subsided, delirium persisted. This
phenomenon may indicate delirious mania cannot be
recognized as the most severe form of mania, as supposed
by Carlson and Goodwin [5]. If we viewed delirious mania
as a syndrome, as proposed by Fink and Taylor, it would
be reasonable because the course of delirious mania and
mania is not the same [12]. Taylor and Fink attributed de-
lirious mania to a form of catatonia because of its good re-
sponse to ECT and the fact that it was frequently
accompanied by catatonic symptoms [8,9,11,12]. They
assumed that delirious mania is prone to occur in patients
with BD, but not solely in BD patients. Following this
logic, delirious mania should not be recognized as a spe-
cific type of episode in BD. So delirious mania could be
superimposed upon BD; in that case, all symptoms looked
like the most severe form of mania, which Carlson and
Goodwin had theorized [5]. In such cases, the effective
treatment could quickly cure delirious mania but it took
longer for mania to remit. In other cases, delirious mania
could abruptly appear in stable BD patients or people
without history of BD [13].
We noticed many literature reports in which patients
remitted within few days under effective treatment, no
matter what kind of treatment they received, leaving no
residual symptoms [8,13]. We surmise that this is a sign
of “simple” delirious mania, which occurs in BD patients
without preceding mania and disappears without on-
going mania. Remitted patients may describe it as being
like “a nightmare” [13]. But we supposed further that de-
lirious mania itself might induce one manic episode or
worsen the ongoing mania. And it is a rational
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longer hospitalization--besides the explanation that no
effective treatment was given [20].
Treatment
Many authors strongly emphasize the efficacy of ECT
for treating delirium, no matter what the etiology is
[8,9,14,16,21]. Two of our patients received ECT. In
patient 4, delirium disappeared after two sessions of
ECT, and her symptoms remitted after six sessions. In
patient 3, after the fourth session of ECT, his orientation
improved while mania shifted to depression. We know
ECT can induce mania [22]. But no cases of ECT-
induced depression have been reported. We theorized
that delirious mania and the manic course subsided at
the same time and mood coincidently switched to
depression. Patient 3 required 17 sessions of ECT to
become stabilized. The three other patients did not re-
ceive ECT treatment because of their relatives’ objec-
tions. In seven cases reported by Fink [8], Strömgren
[16], Friedman et al [17], and Danivas et al [23], orienta-
tion cleared in five patients after two to three sessions of
ECT, and symptoms stabilized in the other 2 patients
after 6 sessions. Six patients in the Karmacharya study
had dramatic improvement and some response within
one to four sessions of ECT [1].
ECT is the treatment of choice for catatonia, regard-
less of the etiology. Catatonic signs are observed in a
few cases of mania [23]. Fink [12] argued that it is of
limited clinical value to differentiate malignant catatonia,
excited catatonia, delirious mania, rapid cycling mania,
and mania with psychotic features, since ECT is remark-
ably effective in relieving each of these syndromes
[23,24]. One case of analgesic (ziconotide)-induced deli-
rious mania was successfully treated with ECT [24]. In
Karmacharya and colleagues’ review of cases [1], ECT
was uniformly beneficial in cases of delirious mania.
High-dose benzodiazepines, especially one-time oral
doses of lorazepam (3 mg to 4 mg) often lead to notice-
able improvement, but not as reliably as does ECT [1].
In patients 1 and 2, at least one kind of benzodiazepine
was given, at most three kinds, all during the course of
treatment. From our clinical observation, our use of
benzodiazepines didn’t lead to resolution of delirium
and mania. But the dosage of benzodiazepines in these
cases was lower than that suggested by Karmacharya.
Although traditional antipsychotics have been used
broadly and successfully to treat delirium [25], some
authors warn that with delirious mania, traditional anti-
psychotics should be avoided [1,7]. So it is inevitable to
suspect that traditional antipsychotics delayed remission
of delirious mania or even worsened it at the first admis-
sion for patient 1. At his second admission, use of anti-
psychotics was limited to new-generation agents, butdelirious mania persisted just as in the first episode.
New-generation antipsychotics with a mood stabilizer
were used without ECT used in patients 2 and 5. Delir-
ium ceased within 1 week of admission in patient 2 and
after 2 more weeks in patient 5. The results in these two
patients echoed those of some new reports that new-
generation antipsychotics may be beneficial for delirious
mania [1,26]. Our findings support Karmacharya and
colleagues’ findings that antipsychotics and mood stabili-
zers alone are less effective in controlling the symptoms
of delirious mania.
In patient 4, delirious mania was accompanied by
prominent catatonic signs. This pointed out a dilemma:
antipsychotics may be beneficial for delirious mania but
they should not be used for catatonia [27]. In this case,
the patient responded to ECT quickly under simultan-
eous use of antipsychotics. But in patient 1, though cata-
tonic signs were not prominent as in patient 3, it is not
known whether antipsychotics were not effective as in
other cases, due to presence of catatonia. Though
Karmacharya didn’t provide the catatonic signs of his
patients, some features may be catatonia-like, for
example, extreme psychomotor agitation (pacing, con-
stant motion), and pouring water (on one’s own head or
on the floor) [1]. Catatonia may be one possible cause
for antipsychotics, especially typical antipsychotics, to be
less effective or detrimental in treating delirious mania.
This is a question that remains to be answered in future
research.
Delirious mania: Catatonia? delirium?
In the DSM-IV, catatonia is primarily categorized as a
subtype of schizophrenia and as a specifier in mood dis-
orders. In Fink’s proposed category, catatonia should be
reclassified into a separate category that requires its own
diagnostic criteria and treatment guidelines different
from those for schizophrenia and mood disorders. Deli-
rious mania should be recognized as a subtype of catato-
nia [10-12]. We used Fink’s criteria for catatonia to
diagnose our patients (Table 1). We found that patient 2
and patient 3 fulfilled the diagnostic criteria. Using
DSM-IV criteria, four of six episodes occurred among
our patients. Catatonia was not very obvious in patient 1
and patient 2 (they were on the borderline of catatonia),
while it was obvious in patient 4. We found that exces-
sive motor activity was the most frequent catatonic sign
in delirious mania. Both patient 1 and patient 2 had
excessive motor activity while patient 1 had posturing at
the first admission, and rigidity of limbs at the second
admission. Patient 2 also had limb rigidity, although this
was attributed to medication. Although our sample size
was small and the review of case reports might be insuf-
ficient, the results were similar to those of Karmacharya
et al. [1] We suggest a larger study to confirm this.
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malignant catatonia (other subtypes: neuroleptic malig-
nant syndrome and serotonin syndrome). Delirious
mania is posited in the milder group, including delirious
catatonia and excited catatonia, rather than malignant
catatonia. Another classification is the use of excited
nonmalignant catatonia for delirious mania [28]. Here
the term “delirious catatonia” seems very appropriate
because it presents the possibility that delirious mania,
which lacks the obvious catatonic signs, and excited
catatonia, which lacks sufficient delirious signs (another
term like catatonic mania), present two ends of the
spectrum of delirious catatonia. In this category, they
share the symptoms of excitement, which is similar to
mania.
The above description raised the question of what is
the line between catatonia and delirium?
In many reviews, delirium could be treated with ECT
[17,24] and the most lethal form of catatonia, malignant
catatonia, also meets the criteria of delirium [29].
Following this logic, although the definitions of delirium
and catatonia had different criteria--delirium diagnosed
mainly from consciousness aspect while catatonia from
movement-- they may share something etiologically.
Using this assumption, it makes sense that no matter
whether the patient has mania with delirium, mania with
catatonia, or both at the same time, the treatment is the
same with ECT.Limitations
The five cases illustrate the challenges to be encountered
in real-world clinical care of patients with delirious
mania; however, the diagnostic workup procedures and
criteria selecting and sequencing treatments were not
uniform for each case. This may reflect the lack of uni-
versally accepted diagnostic criteria for delirious mania,
and lack of widely adopted guidelines for its treatment.
There is only anecdotal-level evidence upon which to
base diagnostic and treatment recommendations. On
this basis, detailed case reports and case series continue
to be valuable for improving case detection in clinical
practice and for providing preliminary guidance in man-
aging delirious mania. However, more rigorous and sys-
temic investigation is needed.Conclusion
Delirious mania is best viewed as a phenomenon differ-
ent from the manic episode alone because it can persist
when mania subsides and disappear when mania per-
sists. Sometimes delirious mania may occur abruptly
without an underlying manic episode, and it can be trea-
ted effectively and immediately without residual symp-
toms. Delirious mania also has a close relationship withcatatonia. Because it can be effectively treated with ECT,
physicians should be alert to this diagnosis.
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